๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients

โœ Scribed by Winnie Yeo; Wing M. Ho; Pun Hui; Paul K. S. Chan; Kwok C. Lam; Jam J. Lee; Philip J. Johnson

Book ID
106376621
Publisher
Springer US
Year
2004
Tongue
English
Weight
97 KB
Volume
88
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Lamivudine in the treatment of hepatitis
Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy
โœ Yeo, Winnie; Steinberg, Joyce L.; Tam, John S.; Chan, Paul K.S.; Leung, Nancy W. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 76 KB ๐Ÿ‘ 2 views

Hepatitis B virus (HBV) reactivation has been described in cancer patients who received cytotoxic/immunosuppressive therapy and may result in liver damage of varying degrees of severity. There is no known effective treatment. Lamivudine, a nucleoside analogue, has been found to suppress HBV replicat

Hepatitis B virus reactivation in breast
Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study
โœ Winnie Yeo; Paul K.S. Chan; Pun Hui; Wing M. Ho; Kwok C. Lam; Wing H. Kwan; Shen ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB

## Abstract Breast cancer is a rapidly increasing problem in many developing countries, and cytotoxic chemotherapy is now an integral part of its management. In several developing countries, the carriage of hepatitis B virus (HBV) in cancer patients may be as high as 12%, and such patients are at r